VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Stool simple
Preclinical
Biologic
H
Hospices Civils de Lyon
1
Indications
2
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
SARS Cov 2 Infection
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
SARS Cov 2 Infection
Preclinical
Completed
Clinical
Trials by Indication
[1]
Crohn's Disease
1 trial
TOward a Better Understanding of the autoPhagy Machinery for the Identification of Potential Novel Biomarkers and Therapeutic Targets in Crohn's Disease - TOPIC Study
Not yet recruiting
·
H
Hospices Civils de Lyon
·
N/A
·
NCT06244849
·
170 enrolled
SARS CoV 2 Infection
1 trial
Host-pathogen Interactions During SARS-CoV-2 Infection
Completed
·
H
Hospices Civils de Lyon
·
N/A
·
NCT04376476
·
140 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Stool simple. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Stool simple compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Stool simple. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Hospices Civils de Lyon company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Preclinical
[1]
Company
H
Hospices Civils de Lyon
Related News